Prudence Dorazio

Statistics

Publications

Citations

622

H-Index

Active since

1997

Affiliations

Hôpital Notre-Dame(Current)

Prudence Dorazio is an author at Hôpital Notre-Dame specializing in cytotoxic t-lymphocyte-associated protein 4 inhibitors, immune checkpoint inhibitors, and oncology.

Publications per year

1997–2010

Publications

Phase II Study of the Anti-Cytotoxic T-Lymphocyte–Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer

Ki Y. Chung, Ira Gore, Lawrence Fong et al. · Journal of Clinical Oncology · 2010 · 307 citations · Full text

Medicine, Oncology, Pharmacology +17

Tremelimumab in Combination with Exemestane in Patients with Advanced Breast Cancer and Treatment-Associated Modulation of Inducible Costimulator Expression on Patient T Cells

Robert H. Vonderheide, Patricia LoRusso, Magi Khalil et al. · Clinical Cancer Research · 2010 · 302 citations

Medicine, Oncology, Pharmacology +17

Antibody kinetics and long-term sero-prevalence in the Italian clinical trial of acellular pertussis vaccines.

Marina Giuliano, Paola Mastrantonio, Anna Giammanco et al. · PubMed · 1997 · 13 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

1–3 of 3